- 1,115
Another important proposal would limit how much commission brokers and agents receive to sell MA plans. Currently, brokers and agents have a cap on their commissions for both MA plans with Part D prescription drug coverage and standalone Part D plans; for 2023, the caps were $601 for each MA initial enrollment and $92 for each Part D initial enrollment. As these numbers show, the commissions are much higher for MA than Part D. In practice, they are even higher as many MA plans skirt these rules and pay brokers additional “administrative” fees, which they claim are necessary to cover certain broker expenses. The proposed rule would bump up the commission level somewhat and eliminate these administrative fees to better level the playing field between smaller MA plans, larger MA plans, and standalone Part D plans. While we strongly support closing this loophole, we urged CMS to do much more to bring MA commissions into alignment with those for Part D to avoid the current incentive to sell MA plans even when they are not the best option for individuals.
[EXTERNAL LINK] - Proposed Rule Would Improve Clarity and Transparency in Medicare Advantage, Boost Access to Care - Medicare Rights Center
[EXTERNAL LINK] - Proposed Rule Would Improve Clarity and Transparency in Medicare Advantage, Boost Access to Care - Medicare Rights Center